RE:Thursday 10/13Guard your expectations, SPCEO, it can't be all that great of news if they don't consider it "material". -LT
SPCEO1 wrote: If you are letting yourself be sidetracked by the cartoonish trading in the stock related to the IV Push approval, you are missing the main point. In six trading days TH will be giving us some information about TH-1902's performance in the phase 1b trial. We cannot know now exactly what that info will be but since no analyst is currently forecasting anything at all for TH-1902, any positive info should help the share price. And there are plenty of signs the info will be positive on some level. Obviously, there is a chance the info they share will be highly positive andthere is not much of a chance of it being negative given how the company ahs been actign recently. So, the odds are skewed in a favorable direction for TH shareholders regarding this event. It makes sense for we extremely patient shareholders to wait out these last six days and see what TH tells us about TH-1902 since there is a good chance it may be info that really triggers other investors to finally start paying attention to the stock. Maybe even including another round of crazed retail investors who this time will be dealing with more accurate info!